Drug Shortage Report for OCTREOTIDE ACETATE OMEGA

Last updated on 2022-10-22 History
Report ID 168210
Drug Identification Number 02248640
Brand name OCTREOTIDE ACETATE OMEGA
Common or Proper name OCTREOTIDE ACETATE INJECTION 100MCG/ML
Company Name OMEGA LABORATORIES LIMITED
Market Status MARKETED
Active Ingredient(s) OCTREOTIDE
Strength(s) 100MCG
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS INTRAVENOUS SUBCUTANEOUS INTRAVENOUS
Packaging size 5 x 1mL vial / fiole
ATC code H01CB
ATC description HYPOTHALAMIC HORMONES
Reason for shortage Shortage of an inactive ingredient or component.
Anticipated start date 2022-09-14
Actual start date 2022-09-09
Estimated end date 2022-10-21
Actual end date 2022-10-21
Shortage status Resolved
Updated date 2022-10-22
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 11177 HAMON
MONTREAL, QUEBEC
CANADA H3M 3E4
Company contact information info@omegalaboratory.com - 1-800-363-0584

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v18 2022-10-22 English Compare
v17 2022-10-20 French Compare
v16 2022-10-20 English Compare
v15 2022-09-30 French Compare
v14 2022-09-30 English Compare
v13 2022-09-23 French Compare
v12 2022-09-23 English Compare
v11 2022-09-18 French Compare
v10 2022-09-18 English Compare
v9 2022-09-13 French Compare
v8 2022-09-13 English Compare
v7 2022-09-08 French Compare
v6 2022-09-08 English Compare
v5 2022-09-07 English Compare
v4 2022-08-30 French Compare
v3 2022-08-30 English Compare
v2 2022-08-30 French Compare
v1 2022-08-30 English Compare

Showing 1 to 18 of 18